News Conference News ACC 2022 New HF Guidelines Stress Four-Drug Approach, ‘HFmrEF,’ Amyloidosis Options, and More Shelley Wood April 01, 2022
News Daily News A ‘Call to Action’ for HF Trials: More Black, Hispanic Patients Caitlin E. Cox March 31, 2022
News Conference News ACC 2022 What’s Going to Be Hot at ACC 2022, In Person or Virtual Shelley Wood March 28, 2022
News Daily News Skipping Low-Value Cardiovascular Care Could Save Billions: AHA Michael O'Riordan March 01, 2022
News Daily News AI-Based Tool IDs Hypertrophic Cardiomyopathy and Cardiac Amyloidosis Yael L. Maxwell February 24, 2022
News Features Reports of Sudden Deaths Among Athletes After COVID-19 Vax Are ‘Misinformation’ Todd Neale February 14, 2022
News Conference News THT 2022 Early Positive Signals From RELIEVE-HF Shift Discussion to Atrial Shunt Size Shelley Wood February 02, 2022
Presentation THT 2022 Inferior Vena Caval Size Monitoring (Fire-1) Presenter: Jeffrey Testani February 01, 2022
News Conference News THT 2022 REDUCE LAP-HF II: Atrial Shunt Device Comes Up Short in HFpEF Shelley Wood February 01, 2022
Presentation THT 2022 The Role of Genetic Testing in Heart Failure (When Should You Order It) Presenter: W. H. Wilson Tang February 01, 2022
Presentation THT 2022 Right heart catheterization + Exercise testing – best practices for treatment selection in patients with PH due to Left Heart Disease Presenter: Ryan Tedford February 01, 2022
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for January 2022 Shelley Wood January 31, 2022
News Daily News Cardiac Abnormalities Seen After COVID-19, but Recovery Is Quick Michael O'Riordan January 20, 2022
News Daily News AHA’s 2021 Top Picks: Headway Continues to Be Made Against CVD Caitlin E. Cox December 28, 2021
News Daily News Women Less Likely Than Men to Experience SCD During Sports Michael O'Riordan December 21, 2021